[The efficacy and safety profile of ixazomib/lenalidomide/dexamethasone in relapsed/refractory multiple myeloma: a multicenter real-world study in China].
Yang Y, Xia ZJ, Zhang WH, Fu CC, Bao L, Chen B, Ding KY, Wang SL, Luo J, Li BZ, Hua LM, Yang W, Zhou X, Wang L, Xu TH, Wang WD, Wu GL, Huang Y, Li J, Liu P.
Yang Y, et al. Among authors: li j, li bz.
Zhonghua Xue Ye Xue Za Zhi. 2021 Aug 14;42(8):628-634. doi: 10.3760/cma.j.issn.0253-2727.2021.08.003.
Zhonghua Xue Ye Xue Za Zhi. 2021.
PMID: 34547867
Free PMC article.
Chinese.